Anaplastic meningioma with abundant extracranial metastases: a case report Authors: Natsumi Toyoda, Nobuyuki Yanagisawa, Reiko Watanabe, Masatomo Doi, Masashi Uchida, Junki Koike Published: 2026 ABSTRACT BackgroundMost meningiomas are classified as WHO CNS grade 1 and have a favorable prognosis when completely resected. In contrast, intracranial recurrence and metastasis are frequently observed in grade 2–3 meningiomas, although extracranial spread is rare.Case presentationA 59-year-old Japanese male presented with numbness on the right side of face and diplopia, and imaging revealed a lesion extending from the right middle cranial fossa to the paranasal sinuses and right optic canal. Histology revealed epithelioid nests and spindle cells with high cellularity. The epithelioid component formed whorl-like structures resembling meningothelial cells, with focal necrosis, bizarre nuclei and lower mitotic activity, which is consistent with atypical meningioma of the meningothelial subtype. In contrast, the spindle cell component demonstrated poor morphological differentiation and high mitotic activity. Immunohistochemistry revealed that the meningothelial cells were positive for epithelial membrane antigen and were partially positive for progesterone receptor. The spindle cells were negative for these markers and weakly positive for smooth muscle actin. The final diagnosis was anaplastic meningioma (WHO CNS grade 3) with sarcomatous features showing smooth muscle differentiation. Extensive extracranial metastases via the sarcomatous element involved 12 extracranial organs, including common sites such as the lungs, bones, and liver, indicating unusually widespread dissemination.ConclusionThis report describes an anaplastic meningioma with multiple extracranial metastases. The extensive multiorgan involvement and rapid progression by the autopsy confirmation distinguish this as a rare case with markedly greater malignancy than typically reported. Introduction Meningiomas exhibit diverse histological subtypes, with the WHO classification recognizing 15 types, including common meningothelial, fibrous, and transitional variants [1]. Most meningiomas are classified as WHO CNS grade 1 and have a favorable prognosis when completely resected. In contrast, intracranial recurrence and metastasis are frequently observed in grade 2–3 meningiomas, although extracranial spread is rare [2]. The reported metastatic sites include the lungs, bones, and liver, but the involvement of ≥ 3 organs is rare [3]. We describe an autopsy case of anaplastic meningioma (WHO grade 3) characterized by rapid progression and extensive metastases to more than 10 extracranial organs. Case presentation A 59-year-old Japanese male presented with numbness on the right side of face. Neurological examinations revealed diplopia due to abducens nerve palsy and facial sensory impairment, and MRI imaging detected a lesion extending from the right middle cranial fossa to the paranasal sinuses and right optic canal (Fig. 1A). No obvious distant metastases were detected in either the initial CT scan or the preoperative PET-CT scan. A paranasal sinus biopsy was nondiagnostic. Following tumor vascular embolization and partial intracranial resection, histological analysis confirmed anaplastic meningioma. The patient received extended local radiotherapy (60 Gy/30 Fr) but subsequently developed recurrent skull base lesions and multiple pulmonary metastases (Fig. 1B, C). Within 3 weeks, the right orbital tumor and bilateral pulmonary metastases enlarged rapidly, leading to death. The clinical timeline is shown in Table 1. A pathological autopsy was performed with written informed consent obtained from his family.Fig. 1A Preoperative MRI (horizontal [left] and frontal [right] views). The tumor extended from the right frontal fossa to the sinus and right optic canal (arrows). B Non-contrast CT at recurrence. The tumor enlarged within the right prefrontal fossa, sinus, and right orbit, displacing the right eyeball (arrows). C Chest CT after recurrence. Multiple lung metastases were detected 6 months postoperatively (top) and showed rapid enlargement 19 days later (bottom)Table 1Clinical timeline of the present caseTime courseEvents0Numbness on the right side of face4 monthsDiplopia due to abducens nerve palsy, facial sensory impairment4 monthsA brain tumor was detected by MRI6 monthsPET-CT confirmed the absence of distant metastases6 monthsTumor embolization6 months + 1 weeksCraniotomy for tumor removal7 monthsBlindness in the right eye8 monthsExtended local irradiation therapy (60 Gy/30fr)12 monthsCT scan revealed lung metastases12 months + 3 weeksIncreased lung metastasis and death A Preoperative MRI (horizontal [left] and frontal [right] views). The tumor extended from the right frontal fossa to the sinus and right optic canal (arrows). B Non-contrast CT at recurrence. The tumor enlarged within the right prefrontal fossa, sinus, and right orbit, displacing the right eyeball (arrows). C Chest CT after recurrence. Multiple lung metastases were detected 6 months postoperatively (top) and showed rapid enlargement 19 days later (bottom) Table 1Clinical timeline of the present caseTime courseEvents0Numbness on the right side of face4 monthsDiplopia due to abducens nerve palsy, facial sensory impairment4 monthsA brain tumor was detected by MRI6 monthsPET-CT confirmed the absence of distant metastases6 monthsTumor embolization6 months + 1 weeksCraniotomy for tumor removal7 monthsBlindness in the right eye8 monthsExtended local irradiation therapy (60 Gy/30fr)12 monthsCT scan revealed lung metastases12 months + 3 weeksIncreased lung metastasis and death Clinical timeline of the present case Pathological examination of surgical specimens The partially resected tumor from the right middle cranial fossa measured up to 4 cm and appeared gray‒white and solid, with a small necrotic focus. Histology revealed epithelioid nests and spindle cells with high cellularity (Fig. 2A). The epithelioid component formed whorl-like structures resembling meningothelial cells, with focal necrosis and bizarre nuclei (Fig. 2B). The level of mitotic activity was low (approximately 1/20 high-power field [HPF, 0.16 mm2]), which is consistent with atypical meningioma of the meningothelial subtype. In contrast, the spindle cell component demonstrated poor morphological differentiation and high mitotic activity (22–29/10 HPF, Fig. 2C), corresponding to the biopsy material from the paranasal sinus. The transition between the two components was focally observed (Fig. 2D). Immunohistochemistry revealed meningothelial cells positive for epithelial membrane antigen (EMA, Fig. 2E), partially positive for progesterone receptor (PgR, Fig. 2F), and positive for somatostatin receptor type 2 (SSTR2). The spindle cells were negative for these markers, weakly positive for smooth muscle actin (SMA; Fig. 2G), partially positive for desmin and caldesmon, and negative for glial fibrillary acidic protein (GFAP) and S-100. The Ki-67 labeling index was ≤ 10% in meningothelial cells and 50–70% in spindle cells (Fig. 2H). Protein expression of trimethylated histone H3 lysine 27 (H3K27me3) and methylthioadenosine phosphorylase (MTAP) was preserved, excluding CDKN2A homozygous deletion. The final diagnosis was anaplastic meningioma (WHO CNS grade 3) with sarcomatous features indicating smooth muscle differentiation.Fig. 2A H&E section of the resected tumor. The tumor comprised meningothelial and spindle cells with indistinct transition zones. (× 100) B Meningothelial cells displayed preserved architecture with focal necrosis (*) and large atypical nuclei. Mitotic activity was low (approximately 1/20 HPF). (× 200) C Spindle cells lacked specific morphological differentiation and demonstrated increased mitotic figures (arrows, approximately 25/10 HPF). (× 200) D Transition from the meningothelial cells (*) to the spindle cells was evident. (× 200) E Epithelial membrane antigen (EMA) immunostaining. Meningothelial cells (*) were positive; spindle cells were completely negative. F Progesterone receptor (PgR) immunostaining. Meningothelial cells (*) were weakly positive in some areas; spindle cells were completely negative. G Smooth muscle actin (SMA) immunostaining. Only spindle cells were positive. H Ki-67 immunostaining. The proliferation index was approximately 10% in meningothelial cells (*), while the high value (50–70%) in spindle cells A H&E section of the resected tumor. The tumor comprised meningothelial and spindle cells with indistinct transition zones. (× 100) B Meningothelial cells displayed preserved architecture with focal necrosis (*) and large atypical nuclei. Mitotic activity was low (approximately 1/20 HPF). (× 200) C Spindle cells lacked specific morphological differentiation and demonstrated increased mitotic figures (arrows, approximately 25/10 HPF). (× 200) D Transition from the meningothelial cells (*) to the spindle cells was evident. (× 200) E Epithelial membrane antigen (EMA) immunostaining. Meningothelial cells (*) were positive; spindle cells were completely negative. F Progesterone receptor (PgR) immunostaining. Meningothelial cells (*) were weakly positive in some areas; spindle cells were completely negative. G Smooth muscle actin (SMA) immunostaining. Only spindle cells were positive. H Ki-67 immunostaining. The proliferation index was approximately 10% in meningothelial cells (*), while the high value (50–70%) in spindle cells Pathological examination of autopsy specimens A coronal section of the cerebrum (Fig. 3A) revealed a 5-cm, gray‒white, ill-defined tumor at the base of the right frontal and temporal lobes. Histology revealed spindle cell invasion of the brain parenchyma (Fig. 3B), sphenoid bone, and right orbit. Additional intracranial metastases, measuring up to 18 mm, were identified in the right frontal lobe, right parietal lobe, and pons.Fig. 3A Frontal section of the autopsied brain. An approximately 5 cm grayish–white tumor with poorly defined margins remained at the base of the right frontal to temporal lobes. B H&E section from the base of the right frontal lobe. Atypical spindle cells (high-grade sarcoma) directly invaded the cerebrum. (× 200) C Macroscopic view of both lungs. Multiple grayish–white metastases, up to 9 cm in diameter, were present bilaterally. Bronchi and hilar vessels were displaced by intrapulmonary and hilar lymph node metastases. D Multiple dark-red metastases were present in the small intestinal mucosa. E H&E section of lung metastases. Atypical spindle cell proliferation (lower right) with intrapulmonary vascular invasion (*) was observed. (× 100) F H&E section of kidney metastases. Short spindle to epithelioid tumor cells infiltrated the renal parenchyma. (× 100) G Smooth muscle actin (SMA) immunostaining. Tumor cells were partially positive with lower expression than in the surgical specimen (ref. Fig. 2G) A Frontal section of the autopsied brain. An approximately 5 cm grayish–white tumor with poorly defined margins remained at the base of the right frontal to temporal lobes. B H&E section from the base of the right frontal lobe. Atypical spindle cells (high-grade sarcoma) directly invaded the cerebrum. (× 200) C Macroscopic view of both lungs. Multiple grayish–white metastases, up to 9 cm in diameter, were present bilaterally. Bronchi and hilar vessels were displaced by intrapulmonary and hilar lymph node metastases. D Multiple dark-red metastases were present in the small intestinal mucosa. E H&E section of lung metastases. Atypical spindle cell proliferation (lower right) with intrapulmonary vascular invasion (*) was observed. (× 100) F H&E section of kidney metastases. Short spindle to epithelioid tumor cells infiltrated the renal parenchyma. (× 100) G Smooth muscle actin (SMA) immunostaining. Tumor cells were partially positive with lower expression than in the surgical specimen (ref. Fig. 2G) Extensive extracranial metastases involved multiple organs, including the bilateral lungs (Fig. 3C, Table 2). The largest pulmonary lesion reached 9 cm, formed by confluent metastatic foci compressing the hilar bronchi and vessels due to tumor emboli and lymph node infiltration (Fig. 3C). Multiple metastases were also present in the small intestine (Fig. 3D). Histologically, spindle-shaped to epithelioid-like cells with moderate to severe atypia resembled the intracranial lesion (Fig. 3E, F). Immunostaining revealed weak EMA positivity in a small fraction and partial SMA positivity with reduced intensity (Fig. 3G). No meningothelial component was identified, confirming distant metastasis of the sarcomatous element. Table 2Extracranial metastases in current caseOrgansNumberMaximum diameter(cm)Lung (bilateral) > 109Lymph nodes > 103.2Pleura/diaphragm > 102Cardiac muscle21Liver > 51.5Kidney (bilateral) > 101Thyroid gland10.6Pancreas11.5Spleen10.5Small intestine > 102Adrenal gland (left)10.7Bone marrow21 Table 2Extracranial metastases in current caseOrgansNumberMaximum diameter(cm)Lung (bilateral) > 109Lymph nodes > 103.2Pleura/diaphragm > 102Cardiac muscle21Liver > 51.5Kidney (bilateral) > 101Thyroid gland10.6Pancreas11.5Spleen10.5Small intestine > 102Adrenal gland (left)10.7Bone marrow21 Extracranial metastases in current case Discussions In the surgical specimen from this case, a meningothelial meningioma–like component positive for EMA and PgR was intermixed with a sarcomatous spindle-cell component that presented reduced EMA and PgR expression and was positive for SMA. The diagnostic criteria for anaplastic meningiomas include the following: (1) histological anaplasia resembling carcinoma, high-grade sarcoma, or melanoma; (2) marked mitotic activity (≥ 20 mitoses/10 HPFs of 0.16 mm2); (3) TERT promoter mutation; and/or (4) homozygous deletion of CDKN2A and/or CDNK2B [1]. This patient met criteria (1) and (2) and was diagnosed with anaplastic meningioma. Although genetic alterations (3) and (4), which are associated with short-term recurrence and progression, could not be assessed, MTAP immunostaining—used as a surrogate marker for homozygous CDKN2A deletion and reported to be useful in meningiomas [4]—showed no protein expression loss. Similarly, there was no loss of H3K27me3 expression, a finding associated with poor prognosis in 21% of anaplastic meningiomas [5]. Thus, immunohistochemical analysis did not reveal any genetic alterations previously linked to poor outcomes in anaplastic meningiomas. Extracranial distant metastasis occurs in only 0.67% of all meningiomas. It is absent in CNS WHO grade 1 tumors, which account for approximately 80% of cases and have a relatively favorable prognosis, but it is more common in grade 2 (2%) and grade 3 (8.6%) meningiomas [4]. Although some reports describe higher rates, these discrepancies are likely due to changes in histological classification [2]. In a study of 155 anaplastic meningiomas, Himič et al. reported that most extracranial metastases involved a single organ (74%), with up to four affected organs, most commonly the lungs (61%), followed by the bones (26%) and liver (19%) [3]. Other studies have reported metastases to the lungs, liver, bones, mediastinum, and abdominal cavity [2, 6–8]. In this case, metastases were detected in 12 extracranial organs, including common sites such as the lungs, bones, and liver, indicating unusually widespread dissemination (Table 2). The use of adjuvant radiotherapy after the surgical resection of anaplastic meningiomas is essential to their treatment. On the other hand, chemotherapy seems to have limited efficacy [9]. Rogers et al. reported that patients with high-risk meningioma treated with IMRT (60 Gy/30 Fr) experienced 3-year progression-free survival of 58.8%, supporting IMRT for meningioma and invite ongoing investigations to improve outcomes further [10]; nevertheless, the effectiveness is limited, and the prognosis for high-grade meningioma remains poor. The present case also received irradiation after tumor resection. However, the interval from biopsy to extracranial metastasis is approximately 7 months, which is markedly shorter than the median time to extracranial metastasis for CNS WHO grade 3 meningiomas (progression-free survival, 4.4 years) [3]. Furthermore, after imaging revealed multiple lung metastases, the disease advanced rapidly, and the patient died within approximately 3 weeks (with a total disease course of approximately 9 months), considerably shorter than the overall survival of 56.9 months reported by Seo et al. [11]. This clinical course suggests a malignancy exceeding that of typical anaplastic meningiomas. The tumor invasion to the epidural space and the sarcomatous component in biopsy specimen were already detected at the early stage, suggesting to rapid and extensive extracranial metastases. Immunohistochemistry revealed weaker SMA expression in the extracranial metastases than in the surgical specimens. While the surgical samples presented weak positive TP53 protein expression, which was consistent with wild-type TP53, the autopsy samples presented complete loss of TP53 expression in both the primary site and the extracranial distant metastases (data not shown). These findings suggest postsurgical tumor evolution toward less differentiation and greater malignancy, potentially involving accumulated genetic alterations such as TP53 mutations. Tumor-to-tumor metastases have frequently been reported in meningiomas [12] and should be distinguished from this case. While most cases have been described as intrameningioma metastasis from carcinomas such as breast cancer [12], only one case each involved renal cell carcinoma metastasis to anaplastic meningioma [13] and intrameningioma metastasis from hepatic angiosarcoma [14], suggesting that both are extremely rare. In this case, only the intracranial lesion was identified by imaging at the time of initial onset, and the presence of the sarcoma element was confirmed in the biopsy sample. In addition, the transition from meningioma to sarcoma was evident (Fig. 2D). Although immunohistochemistry results suggesting a meningioma origin, such as SSTR2, were not obtained in the sarcoma in this case, given the chronological spread of the tumor and the presence of meningioma–sarcoma transition, metastasis of a high-grade sarcoma to an anaplastic meningioma is considered unlikely. Conclusion This report describes an anaplastic meningioma with multiple extracranial metastases after tumor embolization, surgery, and radiation therapy. The extensive multiorgan involvement and rapid progression by the autopsy confirmation distinguish this as a rare case with markedly greater malignancy than typically reported.